Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gareth Hardy

Showing results (11-20 of 14) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 14 results.
The Journal of Infectious Diseases|February 22, 2012
Genetically associated CD16(+)56(-) natural killer cell interferon (IFN)-αR expression regulates signaling and is implicated in IFN-α-induced hepatitis C virus declineSara J Conry, Qinglai Meng, Gareth Hardy, et al.
Plos One|February 1, 2012
Interferon-alpha administration enhances CD8+ T cell activation in HIV infectionMaura Manion, Benigno Rodriguez, Kathleen Medvik, et al.
Clinical Toxicology (Philadelphia, Pa.)|November 2, 2022
Accuracy of substance exposure history in patients attending emergency departments after substance misuse; a comparison with biological sample analysisIshita Virmani, Alberto Oteo, Michael Dunn, et al.
The Journal of Infectious Diseases|October 5, 2010
Determinants of protection among HIV‐exposed seronegative persons: an overviewMichael M Lederman, Galit Alter, Demetre C Daskalakis, et al.
Pageof 2

Showing results (11-20 of 14) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 14 results.
The Journal of Infectious Diseases|February 22, 2012
Genetically associated CD16(+)56(-) natural killer cell interferon (IFN)-αR expression regulates signaling and is implicated in IFN-α-induced hepatitis C virus declineSara J Conry, Qinglai Meng, Gareth Hardy, et al.
Plos One|February 1, 2012
Interferon-alpha administration enhances CD8+ T cell activation in HIV infectionMaura Manion, Benigno Rodriguez, Kathleen Medvik, et al.
Clinical Toxicology (Philadelphia, Pa.)|November 2, 2022
Accuracy of substance exposure history in patients attending emergency departments after substance misuse; a comparison with biological sample analysisIshita Virmani, Alberto Oteo, Michael Dunn, et al.
The Journal of Infectious Diseases|October 5, 2010
Determinants of protection among HIV‐exposed seronegative persons: an overviewMichael M Lederman, Galit Alter, Demetre C Daskalakis, et al.
Pageof 2